Featured
For chronic skin patients, a solution on a global scale
A skin patch developed by Rochester professor of dermatology Lisa Beck and her colleagues to treat a chronic skin condition could one day be used to deliver vaccines without the pain and expense of needles.
Science & Technology
FDA approves new eczema drug tested at URMC
The new drug, Dupilumab, is the first treatment to show significant, lasting results for adults with eczema. The FDA approval is a “game-changer,” says Lisa Beck, professor of dermatology who led three years of clinical trials.